FDA approves Novo Nordisk’s oral Wegovy pill for weight management and cardiovascular risk reduction
Approval covers once-daily oral semaglutide 25 mg based on OASIS and SELECT trial data
Author
Glenmark launches Epinephrine Injection USP multiple-dose vial in the US
Product introduced for institutional channel in the US market
Biocon Biologics secures global manufacturing and commercial rights for Hulio
Agreement with Fujifilm Kyowa Kirin Biologics covers biosimilar Adalimumab
Emcure launches Poviztra semaglutide injection in India
Company begins commercial distribution of Novo Nordisk product for weight management
Piramal Consumer Healthcare unveils Lacto Calamine identity after six decades
Brand marks six decades of skincare use and portfolio expansion
Granules Pharma receives USFDA tentative approval for amphetamine ER ODT ANDA
Approval covers multiple strengths for ADHD treatment, to be manufactured at US facility
Pfizer India partners with Cipla for marketing and distribution of select brands
Cipla to market and distribute five Pfizer medicines in India under new agreement
Alembic Pharmaceuticals gets USFDA final approval for Travoprost Ophthalmic Solution USP, 0.004%
Alembic Pharmaceuticals Limited (Alembic) announced that it has received final approval from the US Food & Drug Administration…
Lupin receives positive CHMP opinion for biosimilar Ranibizumab
Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has…
Senores Pharmaceuticals to acquire Apnar Pharma and five ANDAs
Senores Pharmaceuticals announced that it has entered into a definitive agreement to acquire 100% equity stake in Apnar Pharma,…